Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$2.92
-2.7%
$3.43
$2.73
$6.66
$179.12M0.53994,604 shs1.63 million shs
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$15.94
-1.7%
C$17.62
C$11.98
C$20.56
C$404.73M1.10463129,153 shs18,407 shs
The Supreme Cannabis Company, Inc. stock logo
FIRE
Supreme Cannabis
C$0.00
C$0.12
C$0.60
C$259.40MN/A9.17 million shs2.10 million shs
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$4.39
C$4.55
C$4.11
C$5.77
C$137.30M-0.0225228,710 shs11,094 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
+1.69%-11.24%-9.64%-13.29%-51.22%
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
+0.06%-3.05%-6.84%-6.19%+22.34%
The Supreme Cannabis Company, Inc. stock logo
FIRE
Supreme Cannabis
0.00%0.00%0.00%0.00%0.00%
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
+2.09%+0.92%-4.36%-0.23%-12.02%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$2.92
-2.7%
$3.43
$2.73
$6.66
$179.12M0.53994,604 shs1.63 million shs
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$15.94
-1.7%
C$17.62
C$11.98
C$20.56
C$404.73M1.10463129,153 shs18,407 shs
The Supreme Cannabis Company, Inc. stock logo
FIRE
Supreme Cannabis
C$0.00
C$0.12
C$0.60
C$259.40MN/A9.17 million shs2.10 million shs
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$4.39
C$4.55
C$4.11
C$5.77
C$137.30M-0.0225228,710 shs11,094 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
+1.69%-11.24%-9.64%-13.29%-51.22%
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
+0.06%-3.05%-6.84%-6.19%+22.34%
The Supreme Cannabis Company, Inc. stock logo
FIRE
Supreme Cannabis
0.00%0.00%0.00%0.00%0.00%
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
+2.09%+0.92%-4.36%-0.23%-12.02%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
2.00
HoldN/AN/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
2.00
HoldC$17.006.65% Upside
The Supreme Cannabis Company, Inc. stock logo
FIRE
Supreme Cannabis
0.00
N/AN/AN/A
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
0.00
N/AC$6.0036.67% Upside

Current Analyst Ratings Breakdown

Latest HLS, CPH, FIRE, and ACB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/12/2026
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
Set Price TargetHoldC$17.00
5/1/2026
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
UpgradeSell (E+)Sell (D-)
(Data available from 6/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$320.59M0.56$0.70 per share4.20$6.27 per share0.47
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$50.94M7.95C$4.52 per share3.53C$5.25 per share3.03
The Supreme Cannabis Company, Inc. stock logo
FIRE
Supreme Cannabis
C$53.29M0.00N/A3.90C$0.31 per share0.00
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$55.74M2.46C$0.29 per share15.22C$1.87 per share2.34
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$88.13M-$1.56N/AN/AN/A-33.57%0.10%0.07%8/5/2026 (Estimated)
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$11.41MC$1.1913.39N/AN/A60.82%25.69%7.90%N/A
The Supreme Cannabis Company, Inc. stock logo
FIRE
Supreme Cannabis
N/A-C$0.03N/AN/A0.36N/AN/AN/AN/A
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
-C$15.53M-C$0.32N/AN/AN/A-18.42%-16.54%-2.89%N/A

Latest HLS, CPH, FIRE, and ACB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/11/2026Q4 2026
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$0.07$0.07+$0.14$999.00$54.42 million$60.98 million
5/15/2026Q1 2026
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
N/A-C$0.10N/A-C$0.10N/AC$17.88 million
5/7/2026Q1 2026
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
N/AC$0.33N/AC$0.33N/AC$17.39 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
N/AN/AN/AN/AN/A
The Supreme Cannabis Company, Inc. stock logo
FIRE
Supreme Cannabis
N/AN/AN/AN/AN/A
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
N/A4.30%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.04
5.94
3.32
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
0.32
1.25
2.67
The Supreme Cannabis Company, Inc. stock logo
FIRE
Supreme Cannabis
32.85
1.62
1.12
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
75.00
1.00
1.01

Institutional Ownership

CompanyInstitutional Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
47.63%
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
2.29%
The Supreme Cannabis Company, Inc. stock logo
FIRE
Supreme Cannabis
N/A
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
5.38%

Insider Ownership

CompanyInsider Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.01%
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
42.00%
The Supreme Cannabis Company, Inc. stock logo
FIRE
Supreme Cannabis
N/A
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
0.37%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,13061.34 million61.34 millionOptionable
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
525.39 millionN/ANot Optionable
The Supreme Cannabis Company, Inc. stock logo
FIRE
Supreme Cannabis
400762.93 millionN/ANot Optionable
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
9131.28 millionN/ANot Optionable

Recent News About These Companies

HLS Therapeutics (TSE:HLS) Stock Price Down 1.3% - Here's Why
Should you sell your HLS Therapeutics stock?
HLS Therapeutics Announces Q3 2025 Financial Results
HLS Therapeutics Announces New Credit Agreement

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aurora Cannabis stock logo

Aurora Cannabis NASDAQ:ACB

$2.92 -0.08 (-2.67%)
Closing price 04:00 PM Eastern
Extended Trading
$2.94 +0.02 (+0.68%)
As of 05:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Cipher Pharmaceuticals stock logo

Cipher Pharmaceuticals TSE:CPH

C$15.94 -0.27 (-1.67%)
As of 04:00 PM Eastern

Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.

Supreme Cannabis stock logo

Supreme Cannabis TSE:FIRE

The Supreme Cannabis Company, Inc. engages in the production of medical cannabis products in Canada. The company was formerly known as Supreme Pharmaceuticals Inc. and changed its name to The Supreme Cannabis Company, Inc. in December 2017. The Supreme Cannabis Company, Inc. was incorporated in 1979 and is headquartered in Toronto, Canada.

HLS Therapeutics stock logo

HLS Therapeutics TSE:HLS

C$4.39 0.00 (0.00%)
As of 04:00 PM Eastern

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.